Yong Guo
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 detection and testing 6
- Tuberculosis Research and Epidemiology 3
-
- RNA modifications and cancer 4
- Co-authors
- Lingxiang Zhu (17 shared papers)Arlene Hurley (2 shared papers)Bharat Ramratnam (2 shared papers)Martin Markowitz (2 shared papers)David D. Ho (2 shared papers)Linqi Zhang (2 shared papers)Chianru Tan (11 shared papers)Klara Tenner‐Racz (1 shared paper)
- Journals
- Analytical Chemistry (3 papers)Clinica Chimica Acta (3 papers)The Analyst (2 papers)Microbiology Spectrum (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yong Guo
54 papers receiving 2.3k citations
Yong Guo's Hit Papers
Peers
Comparison fields: 5 of 125
- Virology 715
- Infectious Diseases 1.1k
- Cancer Research 221
- Immunology 231
- Epidemiology 246
Countries citing papers authored by Yong Guo
This map shows the geographic impact of Yong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Guo more than expected).
Fields of papers citing papers by Yong Guo
This network shows the impact of papers produced by Yong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Guo. The network helps show where Yong Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy Hit paper breakdown → | 1999 | 693 |
| 2 | 2020 | 480 | |
| 3 | 2013 | 177 | |
| 4 | 2000 | 148 | |
| 5 | 2005 | 108 | |
| 6 | 2018 | 58 | |
| 7 | 2020 | 48 | |
| 8 | 2011 | 47 | |
| 9 | 2021 | 44 | |
| 10 | 2018 | 44 | |
| 11 | 2018 | 40 | |
| 12 | 2019 | 39 | |
| 13 | Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. | 2009 | 37 |
| 14 | 2010 | 36 | |
| 15 | 2021 | 31 | |
| 16 | 2020 | 31 | |
| 17 | 2012 | 24 | |
| 18 | 2019 | 18 | |
| 19 | 2018 | 18 | |
| 20 | 2020 | 16 |
About Yong Guo
Yong Guo is a scholar working on Infectious Diseases, Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine and Cancer Research, having authored 57 papers that have together received 2.3k indexed citations. Recurring topics across this work include Innovative Microfluidic and Catalytic Techniques Innovation (7 papers), SARS-CoV-2 detection and testing (6 papers), Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (4 papers), Video Coding and Compression Technologies (3 papers), Electrowetting and Microfluidic Technologies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Tuberculosis Research and Epidemiology (3 papers). The work is most often cited by research in Virology (715 citations), Infectious Diseases (1.1k citations), Cancer Research (221 citations), Immunology (231 citations) and Epidemiology (246 citations). Yong Guo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Lingxiang Zhu, Arlene Hurley, Bharat Ramratnam, Martin Markowitz, David D. Ho, Linqi Zhang, Chianru Tan, Klara Tenner‐Racz, Chia-Ching Wang and Paul Rácz. Their work appears in journals such as Analytical Chemistry, Clinica Chimica Acta, The Analyst, Microbiology Spectrum and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.